AI assistant
BiomX Inc. — Director's Dealing 2021
Aug 9, 2021
35099_dirs_2021-08-09_ffd7a1f9-cb82-4858-a707-16b1877146ad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2021-07-28
Reporting Person: Walton Thomas Layton (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.0001 par value | 3637846 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants to purchase Common Stock | $5 | 2027-01-28 | Common Stock (1875000) | Indirect |
Footnotes
F1: These shares of common stock are beneficially owned by the reporting person include (i) 1,137,846 shares of common stock already beneficially owned by the reporting person prior to July 28, 2021, and (ii) 2,500,000 shares of common stock beneficially owned by the reporting person that were purchased in the registered direct offering by BiomX Inc. that closed on July 28, 2021. The securities are directly held by SymBiosis, LLC, over which the reporting person exercises sole investment power.
F2: The warrants are directly held by SymBiosis, LLC, over which the reporting person exercises sole investment power.